傑瑞股份(002353.SZ):傑瑞是全球投放電驅壓裂設備數量最多的企業
格隆匯6月19日丨傑瑞股份(002353.SZ)近期在接待機構現場調研參觀時表示,公司多年前基於對未來市場發展趨勢的研判,提前佈局渦輪壓裂、電驅壓裂市場,並在全球擁有技術領先優勢。其中渦輪壓裂設備方面,傑瑞是唯一一家能夠提供渦輪壓裂成套設備的企業,在北美已實現5套設備銷售,在國內亦實現規模化應用;電驅壓裂設備方面,傑瑞是全球投放電驅壓裂設備數量最多的企業,近期我們在CIPPE展會中推出了由傑瑞自主研發製造的全球首台連續工況8000型電驅壓裂橇,可實現7x24小時連續不間斷作業,滿足大排量、高壓力、長時間作業的需要。未來公司將堅持研發創新,繼續擴大公司技術領先優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.